Glycogen storage disease type I screening: Difference between revisions
No edit summary |
|||
Line 2: | Line 2: | ||
{{Glycogen storage disease type I}} | {{Glycogen storage disease type I}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Anmol}} | ||
==Overview== | ==Overview== | ||
Glycogen storage disease type 1 is an [[autosomal recessive]] disease so [[carrier]] [[Screening (medicine)|screening]] of at-risk relatives may be done. [[Screening (medicine)|Screening]] requires prior identification of [[G6PC]] or [[SLC37A4]] [[pathogenic]] variants in the family. | |||
==Screening== | ==Screening== | ||
*Glycogen storage disease type 1 is an autosomal recessive disease.<ref>Bali DS, Chen YT, Austin S, et al. Glycogen Storage Disease Type I. 2006 Apr 19 [Updated 2016 Aug 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1312/ | *Glycogen storage disease type 1 is an [[autosomal recessive]] disease.<ref>Bali DS, Chen YT, Austin S, et al. Glycogen Storage Disease Type I. 2006 Apr 19 [Updated 2016 Aug 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1312/ | ||
</ref> | </ref> | ||
*Carrier screening of at-risk relatives may be done. | *[[Carrier]] [[Screening (medicine)|screening]] of at-risk relatives may be done. | ||
*Screening requires prior identification of G6PC or SLC37A4 pathogenic variants in the family. | *[[Screening (medicine)|Screening]] requires prior identification of [[G6PC]] or [[SLC37A4]] [[pathogenic]] variants in the family. | ||
==References== | ==References== |
Revision as of 18:59, 21 November 2017
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I screening On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I screening |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Glycogen storage disease type 1 is an autosomal recessive disease so carrier screening of at-risk relatives may be done. Screening requires prior identification of G6PC or SLC37A4 pathogenic variants in the family.
Screening
- Glycogen storage disease type 1 is an autosomal recessive disease.[1]
- Carrier screening of at-risk relatives may be done.
- Screening requires prior identification of G6PC or SLC37A4 pathogenic variants in the family.
References
- ↑ Bali DS, Chen YT, Austin S, et al. Glycogen Storage Disease Type I. 2006 Apr 19 [Updated 2016 Aug 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1312/